4'-methoxyflavone has been researched along with Acute Myelogenous Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauvois, B; Billard, C; Bouchet, S; Dauzonne, D; Piedfer, M; Tang, R | 1 |
1 other study(ies) available for 4'-methoxyflavone and Acute Myelogenous Leukemia
Article | Year |
---|---|
p70S6 kinase is a target of the novel proteasome inhibitor 3,3'-diamino-4'-methoxyflavone during apoptosis in human myeloid tumor cells.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Boronic Acids; Bortezomib; Caspases; Cell Cycle; Cell Proliferation; Colony-Forming Units Assay; Drug Resistance, Neoplasm; Flavonoids; Flow Cytometry; Humans; Immunoenzyme Techniques; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Middle Aged; Phosphorylation; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Ribosomal Protein S6 Kinases, 70-kDa; Tumor Cells, Cultured | 2013 |